The first non-invasive fractional flow reserve technology for assessing coronary artery blockages gained FDA go-ahead Nov. 26.
The agency granted market access to HeartFlow Inc
HeartFlow Cleared To Launch Non-Invasive FFR Software In U.S.
FDA granted market access to HeartFlow's fractional flow reserve-computed tomography software, the first non-invasive fractional flow reserve technology for assessing coronary artery blockages.